Clinical trial · NCT06434168 · ENROLLING_BY_INVITATION · NA
Impact of Yoga on Cognitive Function
Sponsor: Auburn University
Summary
Mild cognitive impairment is highly prevalent in patients with heart failure and results in poor well-being and quality of life. While yoga has proven effective in promoting cognitive health in older adults through its gentle movements, controlled breathing, and meditation, its effects on patients with heart failure remain unknown. Therefore, this feasibility and pilot study plans to deliver a 12-week yoga intervention and test its effects on cognitive function in patients with heart failure and mild cognitive impairment.
Interventions
- Yoga intervention · BEHAVIORAL
Patients in the yoga group will receive a 60-minute session, twice per week over 12 weeks for a total of 24 sessions. Each yoga session consists of a warm-up, yoga postures standing or seated depending on the capability of the patient, and relaxation.
- Control condition · BEHAVIORAL
Patients in the control group will receive care-as-usual from their healthcare providers and will be asked to avoid engaging in yoga during their 3 months in the study.
Published eligibility criteria
Verbatim from the registry. Only the site can decide how these apply to a specific patient.
Inclusion Criteria: * Aged 55 years and older * Confirmed heart failure diagnosis with mild cognitive impairment * New York Heart Association functional class II-IV Exclusion Criteria: * Co-existing neurological disorders, traumatic brain injury, psychiatric disorders, or terminal illnesses * Have implanted defibrillator, left ventricular assist device placement or cardiac transplant * Have any other implanted metals that interfere with the MRI magnetic field for patient safety * Substance abuse * Pregnant * Unable to perform yoga due to physical limitations or severity of illness
Sites (1)
- Auburn University, Auburn, Alabama
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2026-04-06.